Liver transplant is the established treatment for end-stage liver disease with standardized technique and reports of excellent results (1). Elective liver transplant in low risk patients have a 1-year survival rate of more than 90％ (2). Improved outcomes are a result of careful patient selection, meticulous surgical techniques and attentive postoperative care. Increased survival has led to an escalation in the number of liver transplants being performed with over 15,000 patients being transplanted in the USA, Europe and China in 2010 (2). However, 10 to 30％ of patients, submitted to whole organ liver transplantation, develop biliary complications with subsequent mortality of up to 10％ (3,4). Approaches to reduce the incidence of biliary complications have included different techniques for anastomosis (for example side-to-side) and the use of T-tubes for duct-to-duct anastomosis.